SARS CoV-2 RAPID TEST

AN EFFECTIVE SCREENING POINT-of-CARE-TEST

If an infection with SARS-CoV-2 (Corona 2019) is present or not, our rapid test detects in only 20 minutes whether a patient is infected or not.

The detection of SARS-CoV infection is based on the two immunoglobulins IgM and IgG in the blood of the patients.

PERFORMANCE

An essential feature of our Point-of-Care Test is the high specificity for the detection of healthy patients. We have achieved 100% agreement with the PCR smear test in detecting the SARS-CoV-2 virus for non-infected persons.

The test is restricted to healthcare and pharmaceutical professionals.

The daily use of the rapid test relieves the process organisation at doctors and hospitals. Due to the quick and easy risk identification or detection of the infection with SARS-CoV-2, a clear distinction between acutely or previously infected and non-infected patients is possible.

Negative compliance rate
100% conformance rate (specificity rate) for 126 negative controls with subjects not acutely or previously infected with SARS-CoV-2.

Positive compliance rate of the infection
Early stage, day area 4-10:        IgM, 70%
In late stages, area day 11-24:  IgM, 92,3 %.
In late stages, area day11-24:  IgG   98,6%.

APPLICATION OF THE “COV-2 RAPID TEST”-KIT

The application of the test-kit is very simple: Only two drops of capillary blood from the fingertip and 2 drops of flux are needed. The test is evaluated after 20 minutes.

If only the control band “C” is colored, no antibodies against the virus were detected. If one or both test lines IgM and/or IgG show a coloration after 20 minutes, antibodies against the virus are present, so an acute or earlier infection with SARS-CoV-2 is most likely. If a positive IgM test line is visible, this indicates an infection in the early phase (4-10 days). If the positive IgG test line is visible, infection is in a later phase of the disease (11 days or longer).

The evaluation is based on the graph below, which illustrates the course of the infection.


Why is data on testing important?

No country knows the total number of people infected with COVID-19. All we know is the infection status of those who have been tested. All those who have a lab-confirmed infection are counted as confirmed cases. This means that the counts of confirmed cases depend on how much a country actually tests. Without testing there is no data. Testing is our window onto the pandemic and how it is spreading. Without data on who is infected by the virus we have no way of understanding the pandemic. Without this data we can not know which countries are doing well, and which are just underreporting cases and deaths. To interpret any data on confirmed cases we need to know how much testing for COVID-19 the country actually does..

World maps: Confirmed cases 10/05/2020

 

 

 

Number of COVID-19 tests per confirmed case, May 5, 2020